Boomerang Medical

Home
United States
Mountain View, CA
Boomerang Medical

Website

Women-led, clinical-stage co. developing technology to advance the treatment of autoimmune diseases.

10/25/2026

Exciting news! 🌉Palo Alto Medical Foundation (PAMF) has now enrolled a patient in the BOOM-IBD2 pivotal trial.

Behind every enrollment is a team of physicians, coordinators, and staff working behind the scenes. Thank you, PAMF, for joining us in the effort to bring new possibilities to people living with IBD. 🧡

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

And, to the patients who chose to participate, THANK YOU!

Learn more about the trial — link in comments.

10/15/2026

Playoff-caliber enrollment from Kansas! ⚾🧡

Kansas Gastroenterology and Wichita Urology have enrolled FOUR more patients in the BOOM-IBD2 pivotal trial in the last eight days. Now that’s a winning streak!

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

And, to the patients who chose to participate, THANK YOU!

Learn more about the trial — link in comments.

Kansas Gastroenterology, Wichita Urology

10/13/2026

100 patients enrolled!🎆

We’re celebrating a big milestone across our BOOM-IBD pilot study and BOOM-IBD2 pivotal study. A huge thank you to ALL of our clinical partner sites, patients, investigators, and clinical coordinators. We couldn’t have reached this point without your dedication and care.

Here’s to what come next! 🧡

09/23/2026

🎉 Another step forward for BOOM-IBD2!

Kansas Gastroenterology and Wichita Urology enrolled another patient in BOOM-IBD2, the first-ever pivotal trial evaluating a neuromodulation device for the treatment of urgency symptoms in ulcerative colitis.

Living with ulcerative colitis can impact nearly every part of daily life. Today, we’re celebrating another patient who said yes to participating in clinical research—and the dedicated teams who continue to show up for our patients every step of the way.

Every enrollment brings us one step closer to understanding the potential of neuromodulation as a new treatment approach for people living with ulcerative colitis.

Want to learn more about BOOM-IBD2? Link in the comments.

09/10/2026

What has urgency stopped you from doing with the people you love?
Always checking where the bathroom is? Pain. Urgency. Fatigue. The kind of unpredictability that makes planning anything feel uncertain. Living with ulcerative colitis means managing symptoms that don't follow a schedule.
The BOOM-IBD2 study is evaluating a sacral neuromodulation device as an investigational treatment for bowel urgency in ulcerative colitis.
If you or someone you know is living with UC and wants to learn more, visit the link below.

08/21/2026

🎉Another patient said yes to the BOOM-IBD2 clinical trial at Columbia University. We are beyond grateful for the care they bring to every person they enroll!

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

A HUGE thank you to the patient who took this step! Want to learn more about the trial?

Link in comments.

Columbia Surgery

08/13/2026

Thank you Frank, Columbia Surgery, Dr. Marco Zoccali and staff! We couldn’t do this without you!

08/13/2026

🎉And… another patient said yes to the BOOM-IBD2 clinical trial. Thank you to Kansas Gastroenterology and Wichita Urology for the care you bring to every single person you enroll.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

And a HUGE thank you to the patient who took this step! Want to learn more about the trial?

Link in comments.

Kansas Gastroenterology,
Wichita Urology

08/10/2026

Another two patients said yes to the BOOM-IBD2 clinical trial! We are grateful to the Center for Colorectal Innovation team and the care they put into every person they enroll. And, a huge thank you to the patients who took this step!

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

Want to learn more about the trial?

Link in comments.

08/07/2026

We are grateful to the team at HOAG for enrolling another patient in the BOOM-IBD2 clinical trial and to the patient who took this step. The care HOAG puts into every patient truly makes a difference.

BOOM-IBD2 is the first-ever pivotal trial of a neuromodulation device in inflammatory bowel disease. Ulcerative colitis affects millions of people and profoundly impacts their daily lives.

Want to learn more about the trial?

Link in comments.

Address

2495 Hospital Drive, Suite 300, Mountain View, CA 94040
Mountain View, CA
94040

Website

https://boomerangtrial.com/, https://www.boomerangmedical.com/

Alerts

Be the first to know and let us send you an email when Boomerang Medical posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.